Molecular Cancer Therapeutics  Targeting the PI3-Kinase Pathway in Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sah, N. K.
Right arrow Articles by Meyn, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sah, N. K.
Right arrow Articles by Meyn, R. E.
Mol Cancer Ther. 2003;2:1223-1231
© 2003 American Association for Cancer Research

Adenovirus-mediated wild-type p53 radiosensitizes human tumor cells by suppressing DNA repair capacity

Nand K. Sah1, Anupama Munshi1, Takashi Nishikawa1, Tapas Mukhopadhyay2, Jack A. Roth2 and Raymond E. Meyn1

1 Departments of Experimental Radiation Oncology and 2 Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, TX

Requests for reprints: Raymond E. Meyn, Department of Experimental Radiation Oncology, Unit 066, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030. Phone: (713) 792-3424; Fax: (713) 794-5369. E-mail: rmeyn{at}mdanderson.org

Functional inactivation of the p53 gene and robust DNA repair capacity may be among the salient causes of radioresistance in tumor cells. We expressed the wild-type (wt) p53 gene in a p53-mutant human epidermoid carcinoma cell line, A431, using an adenoviral vector [adenovirus-p53 (Ad-p53), INGN 201], examined its radiosensitivity, and correlated p53 status and radiosensitivity with cellular repair functions. Using clonogenic survival assays and the terminal deoxynucleotidyl transferase-mediated nick end labeling assay for apoptosis, we demonstrated that preirradiation treatment with Ad-p53 significantly increased the radiosensitivity of A431 cells over controls. Induction of p53 expression using a construct where p53 expression was under the control of an inducible promoter also significantly increased radiosensitivity of H1299 lung tumor cells, which are otherwise null for p53. These results did not correlate with radiation-induced apoptosis but did correlate with functional impairment of DNA repair and suppressed expression of several repair-related genes, such as Ku70, DNA-dependent protein kinase, ataxia telangiectasia mutated, and X-ray-sensitive complementation group 4. Normal human fibroblast MRC-9 cells showed no impairment in the repair capability due to Ad-p53 despite the suppression of some repair genes. Expression of Ku70, which is known to mediate diverse cellular functions, correlated with the differential effects of p53 on radiosensitivity in the normal and tumor cells.


The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Grant support: P01 CA78778, P01 CA06294, and P30 CA 16672 from the National Cancer Institute.

Present address: Dr. Nand K. Sah, Department of Botany, RD College, Sheikhpura 811105, India.

1 T. Nishikawa, A. Munshi, M. D. Story, S. Chada, and R. E Meyn. Adenoviral-mediated MDA-7 expression suppresses DNA repair capacity and radiosensitizes a non-small cell lung cancer cells, manuscript in preparation.

Received 5/15/03; revised 8/ 8/03; accepted 8/28/03.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
E. Willmore, S. L. Elliott, T. Mainou-Fowler, G. P. Summerfield, G. H. Jackson, F. O'Neill, C. Lowe, A. Carter, R. Harris, A. R. Pettitt, et al.
DNA-Dependent Protein Kinase Is a Therapeutic Target and an Indicator of Poor Prognosis in B-Cell Chronic Lymphocytic Leukemia
Clin. Cancer Res., June 15, 2008; 14(12): 3984 - 3992.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
D. Schaue and W. H. McBride
Counteracting tumor radioresistance by targeting DNA repair
Mol. Cancer Ther., October 1, 2005; 4(10): 1548 - 1550.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.